I had a blood transfusion in 1981 and now have AIDS and I am now blind.
I was wondering if there are any now drugs out that show any new hope if so, can you let me know?
Thank you very much.
Douglas T. Dieterich, M. D.
Chief of Gastroenterology and Hepatology
Cabrini Medical Center
Assoc. Prof. of Medicine NYU School of Medicine
You do not state that you have CMV; however, I guess that we are assuming you do: The advances on
the CMV front have been remarkable in the past 10 years. We first had
ganciclovir and then foscarnet and then cidofovir. The oral
valganciclovir has been approved for several years now too. However, all
these drugs can do is to stop the progression of the eye disease and not
restore vision in a damaged retina. Once the retina is damaged by CMV
that part of it will not see again. There are many helps for the blind
now a days but no drug so far can restore sight.
I wish you the best of luck.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, John M. Lloyd Foundation, Roche and Trimeris, the National Library of Medicine, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, and donations from users like you. Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.